Stay updated on Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.1 to v3.4.2; this appears to be a technical page update with no changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T00:37:50.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page.
    Difference
    0.0%
    Check dated 2026-02-04T23:46:01.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page adds a 'Show glossary' option and includes minor textual/capitalization updates to QC-related labels and revision information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T21:20:25.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-14T04:27:31.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The Related Topics section now includes links for Ovarian cancer and MedlinePlus Genetics. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-31T00:46:31.000Z thumbnail image
  9. Check
    73 days ago
    Change Detected
    Summary
    Added a footer revision note: 'Revision: v3.3.3'. Removed footer links and references to 'HHS Vulnerability Disclosure', 'Ovarian cancer', and 'MedlinePlus Genetics', as well as 'Revision: v3.3.2'.
    Difference
    0.2%
    Check dated 2025-12-23T22:40:31.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemo in Ovarian Cancer Clinical Trial page.